GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Qingdao Vland Biotech Co Ltd (SHSE:603739) » Definitions » Gross-Profit-to-Asset %

Qingdao Vland Biotech Co (SHSE:603739) Gross-Profit-to-Asset % : 16.83% (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Qingdao Vland Biotech Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Qingdao Vland Biotech Co's annualized Gross Profit for the quarter that ended in Mar. 2024 was ¥510 Mil. Qingdao Vland Biotech Co's average Total Assets over the quarter that ended in Mar. 2024 was ¥3,030 Mil. Therefore, Qingdao Vland Biotech Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 was 16.83%.


Qingdao Vland Biotech Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Qingdao Vland Biotech Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qingdao Vland Biotech Co Gross-Profit-to-Asset % Chart

Qingdao Vland Biotech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 36.80 34.25 28.98 20.95 19.75

Qingdao Vland Biotech Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.65 20.41 20.92 22.04 16.83

Competitive Comparison of Qingdao Vland Biotech Co's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Qingdao Vland Biotech Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qingdao Vland Biotech Co's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Qingdao Vland Biotech Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Qingdao Vland Biotech Co's Gross-Profit-to-Asset % falls into.



Qingdao Vland Biotech Co Gross-Profit-to-Asset % Calculation

Qingdao Vland Biotech Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=554.215/( (2578.848+3034.058)/ 2 )
=554.215/2806.453
=19.75 %

Qingdao Vland Biotech Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=509.964/( (3034.058+3026.159)/ 2 )
=509.964/3030.1085
=16.83 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Qingdao Vland Biotech Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Qingdao Vland Biotech Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Qingdao Vland Biotech Co (SHSE:603739) Business Description

Traded in Other Exchanges
N/A
Address
No. 1318, Wangsha Road, Room 108, Enterprise Service Center, Chengyang District, Shandong, Qingdao, CHN, 266061
Qingdao Vland Biotech Co Ltd is a biotechnology company. The company is engaged in research and development of four main product categories which are enzymes, probiotics, vaccines and animal health products.
Executives
Chen Gang Director
Jia De Qiang Director
Cao Cheng Director
Jiang Yong senior management
Xu Yong Supervisors

Qingdao Vland Biotech Co (SHSE:603739) Headlines

No Headlines